Licensing Partnerships Semprus BioSciences offers a permanently dual-functional vascular access surface with covalent bonding, presenting licensing opportunities to catheter manufacturers and coating vendors seeking to differentiate products from standard silver, heparin, and antibiotic coatings.

Durable Surface Advantage The non-leaching, permanently bonded surface aims to reduce infection, thrombosis, and healing complications, offering a long-term clinical and cost-saving advantage over current coatings.

Expansion Potential Although focused on vascular access catheters today, the platform could be extended to other implantable devices, enabling cross-selling opportunities across medical device categories.

Credible Innovation Originating from the MIT Langer Lab with a world-class product development team signals credible science and rigorous development, reducing perceived risk for partners and boosting collaboration appeal.

Market Enablement As a small venture-backed company with limited internal sales and manufacturing scale, pursuing co-development exclusive licensing or distribution partnerships with established medical device players can accelerate commercialization and market uptake.